Ranbaxy Laboratories Buys Russian Generic Drugs Maker Akrikhin For $110 Million
MUMBAI, Aug 21 (Reuters) - Ranbaxy Laboratories Ltd. (RANB.BO: Quote, Profile, Research), India's top drug maker by sales, is close to acquiring Russian generic drugs maker Akrikhin for $100 million, the Business Standard newspaper reported on Monday.